함께 비교하는 진짜 ADC · Antibody · CGT 데이터

ADCBiologicstaleBioAtla, Inc.Phase 2

CAB-AXL-ADC (CAB-AXL-ADC)

Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma · Undifferentiated Pleomorphic Sarcoma

#UndifferentiatedPleomorphicSarco#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

AntibodystaleSutro Biopharma, Inc.Phase 3

Luveltamab tazevibulin (Luveltamab tazevibulin)

Ovarian Cancer; Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase3#항체#면역항체+3

ADCBiologicstaleCancer Institute and Hospital, …Phase 2

QH101 (QH101)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleCancer Institute and Hospital, …Phase 2

IDOV-SAFE (IDOV-SAFE)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleNkarta, Inc.Phase 1

NKG2D CAR-NK (NKG2D CAR-NK)

AML · AML

#AML#CGT#Phase1#세포유전치료#CAR-T+2

ADCBiologicstaleConvalife (Shanghai) Co., Ltd.Phase 2

CVL006 (CVL006)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleNader SanaiPhase 1

Risvutatug rezetecan (Risvutatug rezetecan)

Glioblastoma (GBM); Brain Metastasases · Glioblastoma (GBM)

#GlioblastomaGBM#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX43 DOSE2 + HLX10 (HLX43 DOSE2 + HLX10)

Breast Cancer (Triple Negative Breast Cancer (TNBC)) · Breast Cancer (Triple Negative Breast Ca

#BreastCancerTripleNegativeBreast#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin+Anlotinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

Anti-NY ESO-1 T-cell receptor PBL (Anti-NY ESO-1 T-cell receptor PBL)

Metastatic Melanoma; Metastatic Renal Cell Cancer · Metastatic Melanoma

#MetastaticMelanoma#CGT#Phase2#세포유전치료#CAR-T+3

ADCBiologicstaleSeagenPreclinical

Brentuximab vedotin plus Chidamide (Induction therapy-3 cycles of BvC, Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide))

CD30+ Peripheral T-cell Lymphoma · CD30

#CD30#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleAstraZenecaPhase 3

AZD5335 (AZD5335)

Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

autologous anti-MART-1 F5 T-cell receptor (autologous anti-MART-1 F5 T-cell receptor)

Melanoma; Skin Cancer · Melanoma

#Melanoma#CGT#Phase2#세포유전치료#CAR-T+3

ADCBiologicstaleBio-Thera SolutionsPhase 1

BAT8001 (BAT8001)

HER2-Positive Solid Tumors · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleAstraZenecaPhase 2

Bv-AVD-R (Bv-AVD-R)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleTORL Biotherapeutics, LLCPhase 1

TORL-1-23 (TORL-1-23)

Advanced Solid Tumor; Ovarian Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

IM96 CAR-T cells (IM96 CAR-T cells)

Adenocarcinoma of Gastric; Adenocarcinoma of Esophagogastric Junction · Advanced Solid Tumors

#AdvancedSolidTumors#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

autologous anti-MART-1 F5 T-cell receptor gene-engineered peripheral blood lymphocytes (autologous anti-MART-1 F5 T-cell receptor gene-engineered peripheral blood lymphocytes)

Melanoma · Metastatic Melanoma

#MetastaticMelanoma#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleAlaunos TherapeuticsPhase 2

Neoantigen specific TCR-T cell drug product (Neoantigen specific TCR-T cell drug product)

Gynecologic Cancer; Colorectal Cancer · Gynecologic Cancer

#GynecologicCancer#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleCellectis S.A.Phase 1

UCART123 (UCART123)

Acute Myeloid Leukaemia · Acute Myeloid Leukaemia

#AcuteMyeloidLeukaemia#CGT#Phase1#세포유전치료#CAR-T+2

AntibodystaleGilead SciencesPhase 1

Andecaliximab (Andecaliximab)

Gastric Adenocarcinoma · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase1#항체#면역항체+3

효능 ORR 9.7%임상시험 3상태 DISCONTINUED

CGTBiologicstaleThe Leukemia and Lymphoma Socie…Phase 1

CD22CART infusion (CD22CART infusion)

Leukemia; Acute Lymphoblastic Leukemia · CD22

#CD22#CGT#Phase1#세포유전치료#CAR-T+4

ADCBiologicstaleSeagenPreclinical

Brentuximab vedotin plus chidamide (Consolidation therapy- 3 or 6 cycles of BvC, Consolidation therapy- 3 or 6 cycles of BvC(Brentuximab vedotin plus chidamide))

CD30+ Peripheral T-cell Lymphoma · CD30

#CD30#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleInnovative Cellular Therapeutic…Preclinical

CD19CART (CD19CART)

Leukemia, B-Cell; Lymphoma, B-Cell · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+5